A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

NCT06148792 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1090

Enrollment

OTHER

Sponsor class

Conditions

Vivax Malaria

Interventions

DRUG: Tafenoquine
DRUG: Primaquine

Sponsor

Menzies School of Health Research

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]